State Street Corporation 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 06:15 am Purchase | 2025-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 3,108,145 5.300% | 482,460 (+18.37%) | Filing |
| 2024-01-22 12:37 pm Sale | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 2,625,685 4.700% | -553,383 (-17.41%) | Filing |
| 2023-02-08 09:25 am Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 3,179,068 5.790% | 186,186 (+6.22%) | Filing |
| 2022-02-09 4:36 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 2,992,882 5.510% | 2,992,882 (New Position) | Filing |